Назад
Company hidden
43 минуты назад

Director, Global Value and Health Economics and Outcomes Research (HEOR)

212 000 - 318 000$
Формат работы
remote (только USA)
Тип работы
fulltime
Грейд
director
Английский
b2
Страна
US
Вакансия из списка Hirify.GlobalВакансия из Hirify Global, списка международных tech-компаний
Для мэтча и отклика нужен Plus

Мэтч & Сопровод

Для мэтча с этой вакансией нужен Plus

Описание вакансии

Текст:
/
TL;DR
Director, Global Value and Health Economics and Outcomes Research (HEOR): Leading global and US payer evidence strategy for marketed oncology assets, including lifecycle management, label expansions, value defense, and post-launch evidence generation with an accent on advanced health economic modeling, real-world evidence, and HTA strategy. Focus on building economic models, AMCP and global value dossiers, rare disease registries, comparative effectiveness studies, and payer-facing evidence for complex market access decisions.

Location: US-based, home-based remote role; Philadelphia, Pennsylvania

Base pay: $212,000–$318,000 per year for US-based candidates; additional discretionary bonus, incentive compensation, equity, and benefits may apply.

Company

hirify.global is a global biopharmaceutical company developing medicines for serious diseases, with a portfolio spanning sleep disorders, epilepsy, oncology, and neuroscience.

What you will do

  • Lead global and US payer evidence strategy for marketed oncology assets across label expansions, new formulations, line extensions, competitive shifts, and post-launch lifecycle management.
  • Design and execute evidence programs including comparative effectiveness studies, pragmatic trials, patient registries, real-world observational research, systematic reviews, meta-analyses, Global Value Dossiers, and US AMCP dossiers.
  • Direct US HEOR activities, partnering with Market Access, Pricing and Contracting, Medical Affairs, and Payer Field Teams on payer tools, budget impact models, value summaries, and reactive scientific communications.
  • Develop and adapt cost-effectiveness, cost-utility, budget impact, cost-offset, Markov, partitioned survival, microsimulation, and dynamic population models using clinical and real-world data.
  • Collaborate with EU/INT HEOR teams on HTA reassessments, renewals, conditional reimbursement, pricing negotiations, and global evidence packages.
  • Lead cross-functional governance, publications, vendors, budgets, external partners, and technical mentorship across evidence and value generation activities.

Requirements

  • Master’s degree in Health Economics, Outcomes Research, Pharmacoeconomics, Public Health, or a closely related quantitative field, or a PhD.
  • 7–10 years of experience in HEOR, Global Value, or Health Economics within biopharma or a top-tier HEOR consulting firm.
  • Extensive experience developing post-marketing HEOR strategies, lifecycle evidence roadmaps, label-expansion evidence, and value-defense strategies for marketed pharmaceutical products.
  • Comprehensive knowledge of US managed care, commercial payers, Medicare Part D/Advantage, Medicaid, PBMs, integrated delivery networks, and global HTA environments including EU JCA, NICE, G-BA, and CADTH.
  • Proven expertise building, adapting, and validating economic models using mature clinical trial and real-world data, including Markov, partitioned survival, microsimulation, and dynamic budget impact models.
  • Experience with US payer field enablement, AMCP dossiers, US budget impact models, customer-facing economic tools, and compliance with FDAMA Section 114 and the 21st Century Cures Act.
  • Knowledge of rare disease evidence challenges, including registries, natural history benchmarks, long-term follow-up, surrogate endpoint validation, and specialized reimbursement mechanisms.
  • Working knowledge of major healthcare databases such as IQVIA, Optum, MarketScan, Medicare SAF, disease-specific registries, and electronic health records, plus advanced epidemiological methods.
  • Strong communication, publication, presentation, influencing, cross-functional leadership, and methodological defense skills.
  • Experience leading at least two assets as a US HEOR lead or country-level HTA lead, or equivalent global HEOR product leadership experience.

Nice to have

  • Experience with oncology assets and oncology care pathways.
  • Experience with post-marketing RWE, patient registry studies, and economic evaluations in rare diseases, specialized medicine, or complex chronic conditions.
  • Experience collaborating with EU/INT HEOR teams on HTA reassessments, renewals, or pricing renegotiations.
  • Strong peer-reviewed publication record in health economics and outcomes research.

Culture & Benefits

  • Full-time employment in a global, patient-focused, science-driven biopharmaceutical organization.
  • Remote home-based work for US-based candidates.
  • Medical, dental, and vision insurance; 401(k) retirement savings plan; and flexible paid vacation.
  • Potential eligibility for annual cash bonus or incentive compensation and discretionary equity grants.
  • Equal opportunity and affirmative action employment practices.

Будьте осторожны

Если работодатель просит войти в их систему, используя iCloud/Google, прислать код/пароль, запустить код/ПО, не делайте этого. Это мошенники. Обязательно жмите «Пожаловаться» или пишите в поддержку. Подробнее в гайде →